期刊文献+

肝细胞生长因子在子宫内膜异位症患者血清中的表达及临床意义 被引量:6

Expression and clinical significance of hepatocyt growth factor in endometriosis
下载PDF
导出
摘要 目的探讨肝细胞生长因子(HGF)在子宫内膜异位症(Ems)发病过程中的作用及临床应用价值。方法采用ELISA法检测Ems组、正常组和对照组患者血清HGF的浓度。结果 EMs组血清HGF含量高于正常组、对照组(P均<0.05),Ⅲ~Ⅳ期(88%)Ems患者的HGF高于Ⅰ~Ⅱ期(62%)(P<0.05)。EMs组中单项检测HGF、CA125阳性率分别为71%和60%。HGF和CA125联合检测如以两项之一阳性为阳性判断标准,EMs组阳性率为84%,其中Ⅲ~Ⅳ期患者阳性率高达100%。单项检测血清HGF对Ems诊断的敏感性及特异性(71%、92%)均高于单项检测血清CA125(60%、84%),但两者比较无统计学意义(P>0.05)。HGF和CA125联合检测如以两项均阳性为阳性判断标准,敏感性下降为43%,但特异性为99%,阳性预测值高达100%。结论 HGF可能参与Ems的发病过程,检测血清HGF对Ems的诊断有重要临床参考价值。 Objective To investigate the role of hepatocyt growth factor (HGF) in the pathogenesis of endometriosis (EMs) and its clinical potential value. Method ELISA method was used to detect the expression of HGF in serum of Ems group, normal group and control group. Results The expression of HGF in EMs group was higher than that in control and normal group ( P 〈 O. 05 ), and HGF level in tage Ⅲ -Ⅳ EMs patients (88%) was higher than that in stage Ⅰ - Ⅱ (62%) (P 〈0.05). The positive rate of HGF and CA125 in EMs group were 71% and 60%, respectively. With combined detec- tion of HGF and CA125 (if one of the two was positive, the result was positive), the positive rate was 84% in EMs group, meanwhile which would be up to 100% in stage Ⅲ-Ⅳ. By single detection of serum HGF on diagnosis of EMs, the sensi- tivity and specificity (71%, 92% ) were higher than single detection of serum CA125 (60%, 84% ), but there were no significant difference (P 〉 0. 05). With combined detection of HGF and CA125 (if both of them were positive, the result was positive), the sensitivity dropped to 43%, whereas the specificity was up to 99%, and the positive predictive value elimed up to 100%. Conclusion The expression of HGF might be involved in the pathogenesis of EMs, and detection of the level of serum HGF on the diaeresis of EMs had imoortant clinical potential value.
出处 《山东医药》 CAS 北大核心 2011年第44期7-9,共3页 Shandong Medical Journal
基金 江西省卫生厅中医药科研基金项目(2009A079)
关键词 肝细胞生长因子 血清 子宫内膜异位症 hepatocyte growth factor serum endometriosis
  • 相关文献

参考文献6

二级参考文献28

  • 1宗利丽,李亚里,宋三泰,江泽飞,赵军.子宫内膜异位症患者肝细胞生长因子及其受体c-Met的表达[J].第一军医大学学报,2004,24(6):619-622. 被引量:6
  • 2宗利丽,李亚里,哈小琴.子宫内膜异位症患者腹水与血清中肝细胞生长因子的检测(英文)[J].第一军医大学学报,2003,23(8):757-760. 被引量:12
  • 3Whitehouse C, Solomon E. Current status of the molecular characteri zation of the ovarian cancer antigen CA125 and implications for its use in clinical screening. Gynecol Oncol, 2003, 88:152-157.
  • 4ParrottJA, Skinner MK. Expression and action of hepatocyte growth factor in human and bovine normal ovarian surface epithelium and ovarian cancer. Biol Reprod,2000,62(3) :491-500.
  • 5Mannino T, Gadducci A. Serum market asprognostic factors in epithelial ovarian cancer: an overview. Eur J Gynaecol Oncol, 2000, 21 ( 1 ) :6466-6468.
  • 6Kataoka H, Hamasuna R. Pericellular activation of hepatocyte growth factor/scatter factor(HGF/SF) in colorectal carcinomas:roles of HGF activator(HGFA) and HGFA inhibitor type 1(HAI- 1)[J].Hum Cell,2001;14(1):83-93.
  • 7Parr C, Davies G, Nakamura T, et al. The HGF/SF mduced phosphorylation of paxillin, matrix adhesion, and invasion of prostate cancer cells were suppressed by NK4, an HGF/SF variant[J]. Biochem Biophys Res Commun, 2001; 285 ( 5 ):1330- 1337.
  • 8Maulik G, Shrikhandc A, Kijima T, et al. Role of the hepatocyte growth factor receptor, c - Met, in oncogenesis and potential for therapeutic inhibition [J]. Cytokine Growth Factor Rev,2002;13(1):41-59.
  • 9To CT, Tsao MS. The role ofhepatocyte growth factor/scatter factor and met receptor in human crow, ers[J]. Oncol Rep, 1998 ;5(5): 1013 - 1024.
  • 10Yano H, Hara A, Murase S, et al. Expression of hepatocyte growth factor and matrix metalloproteinase - 2 in human glioma[J]. Bram Tumor Pathol, 2001; 18 ( 1 ): 7 - 12.

共引文献21

同被引文献62

引证文献6

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部